Reduced proliferation and cell adhesion in endometriosis

Molecular Human Reproduction

Volumn 6, Issue 7, 2000, Pages 610-617

  Scotti, S ^a   Regidor, P A ^a   Schindler, A E ^a   Winterhager, E ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Cell adhesion; Endometriosis; Endometrium; Epidermal growth factor; Proliferation

Indexed keywords

ALPHA CATENIN; BETA CATENIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; UVOMORULIN;

ADULT; ARTICLE; CELL ADHESION; CELL PROLIFERATION; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033941629     PISSN: 13609947     EISSN: None     Source Type: Journal    
DOI: 10.1093/molehr/6.7.610     Document Type: Article

References (38)

1. Aberle, H., Schwartz, H. and Kemler, R. (1996) Cadherin-catenin complex: protein interactions and their implications for cadherin function. J. Cell. Biochem., 61, 514-523.
2. Béliard, A., Donnez, J., Nisolle, M. and Foidart, J.M. (1997) Localization of laminin, fibronectin, E-cadherin, and integrins in endometrium and endometriosis. Fertil. Steril., 67, 266-272.
3. Bergqvist, A. and Ferno, M. (1993) Oestrogen and progesterone receptors in endometriotic tissue and endometrium: comparison of different cycle phases and ages. Hum. Reprod., 8, 2211-2217.
4. Bergqvist, I.A. (1995) Hormonal regulation of endometriosis and the rationals and effects of gonadotrophin-releasing hormone agonist treatment: a review. Hum. Reprod., 10, 446-452.
5. Birchmeier, W. and Behrens, J. (1994) Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochem. Biophys. Acta, 1198, 11-26.
6. Birchmeier, W., Hülsken, J. and Behrens, J. (1995) E-cadherin as an invasion suppressor. Ciba. Found. Symp., 189, 124-141.
7. Bonaccorsi, G., Pansini, F., Segala, V. et al. (1989) Modification of number and affinity of endometrial EGF receptors during menstrual cycle. Eur. J. Obstet. Gynecol. Reprod. Biol., 33, 177-182.
8. Chegini, N., Rossi, M.J. and Masterson, B.J. (1992) Platelet-derived growth factor (PDGF), epidermal growth factor (EGF), and EGF and PDGF β-receptors in human endometrial tissue: Localization and in vitro action. Endocrinology, 130, 2373-2385.
9. Gaetje, R., Kotzian, S., Herrmann, G. et al. (1995) Invasiveness of endometriotic cells in vitro. Lancet, 346, 1463-1464.
10. Gaetje, R., Kotzian, S., Herrmann, G. et al. (1997) Nonmalignant epithelial cells, potentially invasive in human endometriosis, lack the tumor suppressor molecule E-cadherin. Am. J. Pathol., 150, 461-467.
11. Gebel, H.M., Braun, D.P., Tambur, A. et al. (1998) Spontaneous apoptosis of endometrial tissue is impaired in women with endometriosis. Fertil. Steril., 69, 1042-1047.
12. Haining, R.E., Cameron, I.T., van Papendorp, C. et al. (1991) Epidermal growth factor in human endometrium: proliferative effects in culture and immunocytochemical localization in normal and endometriotic tissue. Hum. Reprod., 6, 1200-1205.
13. Huang, J.C. and Yeh, J. (1994) Quantitative analysis of epidermal growth factor receptor gene expression in endometriosis. J. Clin. Endocrinol. Metab., 79, 223-226.
14. Huber, O., Korn, R., Mclaughlin, J. et al. (1996) Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech. Dev., 59, 3-10.
15. Imai, T., Kurachi, H., Adachi, K. et al (1995) Changes in epidermal growth factor receptor and the levels of its ligands during menstrual cycle in human endometrium. Biol. Reprod., 52, 928-938.
16. Jones, R.K., Bulmer, J.N. and Searle, R.F. (1995) Immunohistochemical characterization of proliferation, oestrogen receptor and progesterone receptor expression in endometriosis: comparison of eutopic and ectopic endometrium with normal cycling endometrium. Hum. Reprod., 10, 3272-3279.
17. Koninckx, P.R., Kennedy, S.H. and Barlow, D.H. (1998) Endometriotic disease: the role of peritoneal fluid. Hum. Reprod. Update, 4, 741-751.
18. Konopka, B., Skasko, E., Kluska, A. et al. (1998) Changes in the concentrations of receptors of insulin-like growth factor-I, epithelial growth factor, oestrogens and progestagens in adenomyosis foci, endometrium and myometrium of women during menstrual cycle. Eur. J. Gynaecol. Oncol., 19, 93-97.
19. Li, S.F., Nakayama, K., Masuzana, H. and Fujii, S. (1993) The number of proliferating cell nuclear antigen positive cells in endometriotic lesions differs from that in endometrium. Virchows Arch. Abt. A., 423, 257-263.
20. Liu, D.T. and Hitchcock, A. (1986) Endometriosis: its association with retrograde menstruation, dysmenorrhoea and tubal pathology. Br. J. Obstet. Gynaecol., 93, 859-862.
21. McBean, J.H., Brumsted, J.R. and Stirewalt, W.S. (1997) In vivo estrogen regulation of epidermal growth factor receptor in human endometrium. J. Clin. Endocrinol. Metab., 82, 1467-1471.
22. McCullagh and Neider (1989) Generalized Linear Models. 2nd edn. Chapman and Hall, Letchworth, Herts, UK. pp. 124-125.
23. Mukku, V.R. and Stancel, G.M. (1985) Regulation of epidermal growth factor receptor by estrogen. J. Biol. Chem., 260, 9820-9824.
24. Nelson, K.G., Takahashi, T., Bessert, N.L. et al. (1991) Epidermal growth factor replaces estrogen in the stimulation of female genital-tract growth and differentiation. Proc. Natl Acad. Sci. USA, 88, 21-25.
25. Niikura, H., Sasano, H., Kaga, K. et al. (1996) Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium. Hum. Pathol., 27, 382-389.
26. Nisolle, M., Casanas-Roux, F. and Donnez, J. (1997) Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis. Fertil. Steril., 68, 912-919.
27. Novak, A., Hsu, S.C., Leung-Hagesteijn, C. et al. (1998) Cell adhesion and the integrin-linked kinase regulate the LEF-1 and β-catenin signaling pathways. Proc. Natl Acad. Sci. USA, 95, 4374-4379.
28. Prentice, A., Randall, B.J., Wedell, A. et al. (1992) Ovarian steroid receptor expression in endometriosis and in two potential parent epithelia: endometrium and peritoneal mesothelium. Hum. Reprod., 7, 1318-1325.
29. Regidor, P.A., Schindler, A.E., Bühler, K. et al. (1996) Ergebnisse eines Langzeit Follow-up bei der Behandlung der Endometriose mit dem GnRH-Agonisten Leuprorelinacetat-Depot (Enantone® -Gyn Monats-Depot). Zentralbl. Gynäkol., 118, 283-290.
30. Roy, R.N., Gerulath, A.H., Cecutti, A. and Bhavnani, B.R. (1999) Discordant expression of insulin-like growth factors and their receptor messenger ribonucleic acids in endometrial carcinomas relative to normal endometrium. Mol. Cell. Endocrinol., 153, 19-27.
31. Schweppe, K.W., Dmowski, W.P. and Rolland, R. (1990) Endometriose, Pathophysiologie, Klinik und neue Behandlungsmöglichkeiten. Aktuelles Wissen Hoechst. Hoechst, Frankfurt am Main, Germany, pp. 26.
32. Shtutman, M., Zhurinsky, J., Simcha, I. et al. (1999) The cyclin D1 gene is a target of the beta-catenin / LEF-1 pathway. Proc. Natl Acad. Sci. USA, 96, 5522-5527.
33. Smith, S.K. (1994) Growth factors in the human endometrium. Hum. Reprod., 9, 936-946.
34. Starzinski-Powitz, A., Gaetje, R., Zeitvogel, A. et al. (1998) Tracing cellular and molecular mechanisms involved in endometriosis. Hum. Reprod, Update, 4, 724-729.
35. Troche, V., O'Connor, D.M. and Schaudies, R.P. (1991) Measurement of human epidermal growth factor receptor in the endometrium during the menstrual cycle. Am. J. Obstet. Gynecol., 165, 1499-1503.
36. Van der Linden, P.J.Q., de Goeij, A.F.P.M., Dunselman, G.A.J. et al. (1994) Expression of integrins and E-cadherin in cells from menstrual effluent, endometrium, peritoneal fluid, peritoneum, and endometriosis. Fertil. Steril., 61, 85-90.
37. Vleminckx, K., Vakaet, L., Mareel, M. et al. (1991) Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell, 66, 107-119.
38. Wingfield, M., Macpherson, A., Healy, D.L. and Rogers, P.A. (1995) Cell proliferation is increased in the endometrium of women with endometriosis. Fertil. Steril., 64, 340-346.